Specifications
Immunogen
Synthetic peptide corresponding to a region within the internal sequence amino acids 36-85 (KDIAAHIKKEFDKKYNPTWHCIVGRNFGSYVTHETKHFIYFYLGQVAIL L) of Human DLC8 (NP_001032583).
Applications
Application Notes
WB: 1 μg/ml.
Target
Alternative Names
DYNLL1; dynein, light chain, LC8-type 1; DNCL1, dynein, cytoplasmic, light polypeptide 1; dynein light chain 1, cytoplasmic; DLC1; DLC8; hdlc1; LC8; PIN; 8 kDa dynein light chain; cytoplasmic dynein light polypeptide; dynein, cytoplasmic, light polypeptid
Product Background
Antigen Description
Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in changing or maintaining the spatial distribution of cytoskeletal structures.Binds and inhibits the catalytic activity of neuronal nitric oxide synthase.Promotes transactivation functions of ESR1 and plays a role in the nuclear localization of ESR1.Regulates apoptotic activities of BCL2L11 by sequestering it to microtubules. Upon apoptotic stimuli the BCL2L11-DYNLL1 complex dissociates from cytoplasmic dynein and translocates to mitochondria and sequesters BCL2 thus neutralizing its antiapoptotic activity.
Pathway
Activation of BH3-only proteins; Activation of BIM and translocation to mitochondria; Apoptosis; Cell Cycle; Cell Cycle, Mitotic; Centrosome maturation; G2/M Transition
Citations
Publication ()
Have you cited DPABH-18865 in a publication?
Let us know and earn a reward for your research.